Artificial Intelligence

A single-dose therapy wiped out aggressive glioblastoma tumors in a landmark pre-clinical study, paving the way for human trials in 2026.

As AI and automation reshape global tax, a new online certificate from IBFD and VU Amsterdam aims to equip professionals with crucial, future-proof skills.

A new report reveals a massive security blind spot. Unmanaged apps, fueled by AI adoption, are causing data breaches, audit failures, and huge financial losses.

Sweed hires tech growth expert Brad Cross as CRO, signaling a major push to dominate the dispensary tech market with its all-in-one AI platform.

A major upgrade to RxERP's platform introduces unit-level audit logging, promising to redefine data integrity and drive efficiency beyond simple compliance.

A new app lets users bet on viral videos, raising over $1M to financialize social media. But does it create a new economy or a new set of risks?

In 2025, a non-profit delivered 53,000 hours of free virtual programs, from pet painting to yoga, creating a new blueprint for aging well.

With B2B firms struggling to execute strategy, 2X appoints Emily Atkinson as CCO to operationalize its unified GTM engine and close the widening gap.

Progressive Grocer’s annual awards name 68 top products, revealing key trends in sustainability, wellness, and global flavors shaping our grocery carts.

The WODMDX 2026 expo returns to Shanghai, leveraging a unique 'precision matching' model to connect global tech with China's industrial giants.

Retired NASA astronaut and UMD alumna Dr. Jeanette Epps will inspire the Class of 2026, bringing her story of 'fearless determination' back to campus.

Absci will showcase its generative AI drug discovery platform at a key healthcare conference, highlighting its ambitious pipeline for hair loss and endometriosis.

With stellar trial data for its cholesterol drug obicetrapib, NewAmsterdam Pharma faces investors as it navigates a competitive market and awaits key results.

As uranium prices soar, one explorer uses advanced 3D modeling and AI to unlock new discovery potential in Canada's richest uranium district.

As Spectral AI preps its revolutionary DeepView wound scanner for launch, new CFO David McGuire brings crucial public company expertise to a pivotal transition.

Ovid Therapeutics is spotlighting a novel drug class targeting KCC2, a key brain protein. Could this be the key to treating psychosis and epilepsy?

CorTec's brain-computer interface gets FDA Breakthrough status, offering new hope for restoring movement in millions of chronic stroke survivors.

A landmark test proves new 9-1-1 location tech meets federal mandates, offering telecoms a clear path to compliance and promising to save lives.

After years of development, Solar Roadways is deploying its new SR5 panel at a military base and seeking investment to scale its intelligent pavement.

Acclaro Medical's new AuraLux laser combines 'cold ablative' tech with a unique business partnership, aiming to make advanced skin treatments safe for all.